They may pull something off but I did sell plenty in the lead up to 30 June to offset some big gains (all explained in Post #:74207820 ) and what I have left is more than enough to benefit if they ever manage to get some sort of license deal or an opportunistic takeover does by chance happen ?
The other 'red flag' IMHO is the fact that neither Merck nor Genentech (the supposed only 2 left in the funnel as per new CEO Webinar, which is also highlighted in the above post number) haven't made a takeover offer while the market cap is so depressed if the science has proven to be so good in their years of research ?
You would have to think it was a bargain to Merck if the Starpharma ADC's were proven in any way in the 3 years Merck has been researching them at say 50 cps in comparison to the $22 billion they have committed elsewhere ..... so again I ask the forum - why haven't they if the science is so good ?
AstraZeneca don't appear to be interested anymore either after their AZD0466 flop and they have spent almost a decade researching Starpharma DEP combinations - surely if the science showed any promise in almost 10 years they would make a move while we sit at penny dreadful status ?
https://starpharma.com/assets/asxannouncements/150907_Starpharma_AZ_announcemen.pdf
.....a truly sad state of affairs after all that was touted to the market in the last 5 years
